Abstract
To the Editor: Inflammatory skin reactions have been associated with immune checkpoint inhibitors.1 These cutaneous immune-related adverse events (cirAE) encompass common dermatoses including eczema and psoriasis, as well as lichenoid, maculopapular, and immunobullous eruptions.1 Although identification of risk factors for specific cirAE could potentially improve outcomes, research on the association of dermatologic history and morphologic patterns of cirAE is lacking.2
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have